Axonics® Announces 1-Year Top-Line Clinical Results from its ARTISAN-SNM Pivotal Study
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel...